
Sign up to save your podcasts
Or


Kathryn Tucker serves as the National Psychedelics Association's Director of Advocacy, and she has seen first-hand how psilocybin and other psychedelics can impact end of life care and mental health. While progress has been made, she joined the CLYDE Collision Podcast to discuss the hurdles still faced by those who need it most.
By CLYDEKathryn Tucker serves as the National Psychedelics Association's Director of Advocacy, and she has seen first-hand how psilocybin and other psychedelics can impact end of life care and mental health. While progress has been made, she joined the CLYDE Collision Podcast to discuss the hurdles still faced by those who need it most.